Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(0.94)
# 3,526
Out of 4,814 analysts
368
Total ratings
21.2%
Success rate
-17.82%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VYGR Voyager Therapeutics | Reiterates: Buy | $30 | $3.35 | +796.86% | 10 | Apr 8, 2025 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $70 | $28.85 | +142.63% | 6 | Apr 8, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $10 | $2.30 | +334.78% | 1 | Apr 7, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.76 | +1,211.30% | 25 | Apr 7, 2025 | |
| BEAM Beam Therapeutics | Reiterates: Buy | $80 | $18.17 | +340.29% | 8 | Apr 7, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $4.81 | +149.48% | 17 | Apr 3, 2025 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $500 | $230.86 | +116.58% | 26 | Apr 2, 2025 | |
| MIST Milestone Pharmaceuticals | Maintains: Buy | $25 → $10 | $0.99 | +910.82% | 19 | Apr 1, 2025 | |
| DTIL Precision BioSciences | Reiterates: Buy | $60 | $5.16 | +1,062.79% | 17 | Mar 28, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $10 | $0.51 | +1,856.95% | 17 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.42 | +604.23% | 18 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.81 | +1,137.62% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $29.88 | +234.67% | 20 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.58 | +765.65% | 17 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $5.71 | +863.22% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $3.07 | +2,343.00% | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $3.34 | +1,247.31% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $13.72 | +410.20% | 13 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $5.69 | +1,833.22% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $32.93 | +158.12% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $7.47 | +1,908.03% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $12.23 | +554.13% | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $9.32 | +329.18% | 14 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $13.70 | +396.35% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $20 | $0.32 | +6,069.03% | 2 | Dec 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $233.34 | +45.71% | 1 | Aug 18, 2021 |
Voyager Therapeutics
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $3.35
Upside: +796.86%
Harmony Biosciences Holdings
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $28.85
Upside: +142.63%
Alto Neuroscience
Apr 7, 2025
Initiates: Buy
Price Target: $10
Current: $2.30
Upside: +334.78%
Sangamo Therapeutics
Apr 7, 2025
Reiterates: Buy
Price Target: $10
Current: $0.76
Upside: +1,211.30%
Beam Therapeutics
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $18.17
Upside: +340.29%
Altimmune
Apr 3, 2025
Reiterates: Buy
Price Target: $12
Current: $4.81
Upside: +149.48%
Alnylam Pharmaceuticals
Apr 2, 2025
Reiterates: Buy
Price Target: $500
Current: $230.86
Upside: +116.58%
Milestone Pharmaceuticals
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $0.99
Upside: +910.82%
Precision BioSciences
Mar 28, 2025
Reiterates: Buy
Price Target: $60
Current: $5.16
Upside: +1,062.79%
Invivyd
Mar 26, 2025
Reiterates: Buy
Price Target: $10
Current: $0.51
Upside: +1,856.95%
Mar 19, 2025
Reiterates: Buy
Price Target: $10
Current: $1.42
Upside: +604.23%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.81
Upside: +1,137.62%
Mar 12, 2025
Reiterates: Buy
Price Target: $100
Current: $29.88
Upside: +234.67%
Mar 10, 2025
Reiterates: Buy
Price Target: $5
Current: $0.58
Upside: +765.65%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $5.71
Upside: +863.22%
Mar 7, 2025
Reiterates: Buy
Price Target: $75
Current: $3.07
Upside: +2,343.00%
Mar 4, 2025
Reiterates: Buy
Price Target: $45
Current: $3.34
Upside: +1,247.31%
Mar 4, 2025
Reiterates: Buy
Price Target: $70
Current: $13.72
Upside: +410.20%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $5.69
Upside: +1,833.22%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $32.93
Upside: +158.12%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $7.47
Upside: +1,908.03%
Feb 12, 2025
Reiterates: Buy
Price Target: $80
Current: $12.23
Upside: +554.13%
Jan 27, 2025
Reiterates: Buy
Price Target: $40
Current: $9.32
Upside: +329.18%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $13.70
Upside: +396.35%
Dec 28, 2021
Maintains: Buy
Price Target: $230 → $20
Current: $0.32
Upside: +6,069.03%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $233.34
Upside: +45.71%